1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Polyneuropathy Treatment 1.2.3 Spinal Muscular Atrophy (SMA) Treatment 1.2.4 Huntington’s Disease Treatment 1.3 Market by Application 1.3.1 Global CNS Specific Antisense Oligonucleotides Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global CNS Specific Antisense Oligonucleotides Market Perspective (2016-2027) 2.2 CNS Specific Antisense Oligonucleotides Growth Trends by Regions 2.2.1 CNS Specific Antisense Oligonucleotides Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 CNS Specific Antisense Oligonucleotides Historic Market Share by Regions (2016-2021) 2.2.3 CNS Specific Antisense Oligonucleotides Forecasted Market Size by Regions (2022-2027) 2.3 CNS Specific Antisense Oligonucleotides Industry Dynamic 2.3.1 CNS Specific Antisense Oligonucleotides Market Trends 2.3.2 CNS Specific Antisense Oligonucleotides Market Drivers 2.3.3 CNS Specific Antisense Oligonucleotides Market Challenges 2.3.4 CNS Specific Antisense Oligonucleotides Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top CNS Specific Antisense Oligonucleotides Players by Revenue 3.1.1 Global Top CNS Specific Antisense Oligonucleotides Players by Revenue (2016-2021) 3.1.2 Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Players (2016-2021) 3.2 Global CNS Specific Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by CNS Specific Antisense Oligonucleotides Revenue 3.4 Global CNS Specific Antisense Oligonucleotides Market Concentration Ratio 3.4.1 Global CNS Specific Antisense Oligonucleotides Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by CNS Specific Antisense Oligonucleotides Revenue in 2020 3.5 CNS Specific Antisense Oligonucleotides Key Players Head office and Area Served 3.6 Key Players CNS Specific Antisense Oligonucleotides Product Solution and Service 3.7 Date of Enter into CNS Specific Antisense Oligonucleotides Market 3.8 Mergers & Acquisitions, Expansion Plans 4 CNS Specific Antisense Oligonucleotides Breakdown Data by Type 4.1 Global CNS Specific Antisense Oligonucleotides Historic Market Size by Type (2016-2021) 4.2 Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Type (2022-2027) 5 CNS Specific Antisense Oligonucleotides Breakdown Data by Application 5.1 Global CNS Specific Antisense Oligonucleotides Historic Market Size by Application (2016-2021) 5.2 Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America CNS Specific Antisense Oligonucleotides Market Size (2016-2027) 6.2 North America CNS Specific Antisense Oligonucleotides Market Size by Type 6.2.1 North America CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) 6.2.2 North America CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) 6.2.3 North America CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2027) 6.3 North America CNS Specific Antisense Oligonucleotides Market Size by Application 6.3.1 North America CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) 6.3.2 North America CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) 6.3.3 North America CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2027) 6.4 North America CNS Specific Antisense Oligonucleotides Market Size by Country 6.4.1 North America CNS Specific Antisense Oligonucleotides Market Size by Country (2016-2021) 6.4.2 North America CNS Specific Antisense Oligonucleotides Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe CNS Specific Antisense Oligonucleotides Market Size (2016-2027) 7.2 Europe CNS Specific Antisense Oligonucleotides Market Size by Type 7.2.1 Europe CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) 7.2.2 Europe CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) 7.2.3 Europe CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2027) 7.3 Europe CNS Specific Antisense Oligonucleotides Market Size by Application 7.3.1 Europe CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) 7.3.2 Europe CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) 7.3.3 Europe CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2027) 7.4 Europe CNS Specific Antisense Oligonucleotides Market Size by Country 7.4.1 Europe CNS Specific Antisense Oligonucleotides Market Size by Country (2016-2021) 7.4.2 Europe CNS Specific Antisense Oligonucleotides Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size (2016-2027) 8.2 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Type 8.2.1 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) 8.2.2 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) 8.2.3 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2027) 8.3 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Application 8.3.1 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) 8.3.2 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) 8.3.3 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2027) 8.4 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region 8.4.1 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region (2016-2021) 8.4.2 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America CNS Specific Antisense Oligonucleotides Market Size (2016-2027) 9.2 Latin America CNS Specific Antisense Oligonucleotides Market Size by Type 9.2.1 Latin America CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) 9.2.2 Latin America CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) 9.2.3 Latin America CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2027) 9.3 Latin America CNS Specific Antisense Oligonucleotides Market Size by Application 9.3.1 Latin America CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) 9.3.2 Latin America CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) 9.3.3 Latin America CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2027) 9.4 Latin America CNS Specific Antisense Oligonucleotides Market Size by Country 9.4.1 Latin America CNS Specific Antisense Oligonucleotides Market Size by Country (2016-2021) 9.4.2 Latin America CNS Specific Antisense Oligonucleotides Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size (2016-2027) 10.2 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Type 10.2.1 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) 10.2.2 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) 10.2.3 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2027) 10.3 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Application 10.3.1 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) 10.3.2 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) 10.3.3 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2027) 10.4 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country 10.4.1 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country (2016-2021) 10.4.2 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Akcea Therapeutics, Inc. 11.1.1 Akcea Therapeutics, Inc. Company Details 11.1.2 Akcea Therapeutics, Inc. Business Overview 11.1.3 Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Introduction 11.1.4 Akcea Therapeutics, Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) 11.1.5 Akcea Therapeutics, Inc. Recent Development 11.2 Ionis Pharmaceuticals Inc. 11.2.1 Ionis Pharmaceuticals Inc. Company Details 11.2.2 Ionis Pharmaceuticals Inc. Business Overview 11.2.3 Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Introduction 11.2.4 Ionis Pharmaceuticals Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) 11.2.5 Ionis Pharmaceuticals Inc. Recent Development 11.3 Biogen Inc. 11.3.1 Biogen Inc. Company Details 11.3.2 Biogen Inc. Business Overview 11.3.3 Biogen Inc. CNS Specific Antisense Oligonucleotides Introduction 11.3.4 Biogen Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) 11.3.5 Biogen Inc. Recent Development 11.4 Sarepta Therapeutics 11.4.1 Sarepta Therapeutics Company Details 11.4.2 Sarepta Therapeutics Business Overview 11.4.3 Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Introduction 11.4.4 Sarepta Therapeutics Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) 11.4.5 Sarepta Therapeutics Recent Development 11.5 Wave Life Sciences Ltd. 11.5.1 Wave Life Sciences Ltd. Company Details 11.5.2 Wave Life Sciences Ltd. Business Overview 11.5.3 Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Introduction 11.5.4 Wave Life Sciences Ltd. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) 11.5.5 Wave Life Sciences Ltd. Recent Development 11.6 Dynacure 11.6.1 Dynacure Company Details 11.6.2 Dynacure Business Overview 11.6.3 Dynacure CNS Specific Antisense Oligonucleotides Introduction 11.6.4 Dynacure Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) 11.6.5 Dynacure Recent Development 11.7 ProQR Therapeutics N.V. 11.7.1 ProQR Therapeutics N.V. Company Details 11.7.2 ProQR Therapeutics N.V. Business Overview 11.7.3 ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Introduction 11.7.4 ProQR Therapeutics N.V. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) 11.7.5 ProQR Therapeutics N.V. Recent Development 11.8 Stroke Therapeutic Inc. 11.8.1 Stroke Therapeutic Inc. Company Details 11.8.2 Stroke Therapeutic Inc. Business Overview 11.8.3 Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Introduction 11.8.4 Stroke Therapeutic Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) 11.8.5 Stroke Therapeutic Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Polyneuropathy Treatment Table 3. Key Players of Spinal Muscular Atrophy (SMA) Treatment Table 4. Key Players of Huntington’s Disease Treatment Table 5. Global CNS Specific Antisense Oligonucleotides Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global CNS Specific Antisense Oligonucleotides Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global CNS Specific Antisense Oligonucleotides Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global CNS Specific Antisense Oligonucleotides Market Share by Regions (2016-2021) Table 9. Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global CNS Specific Antisense Oligonucleotides Market Share by Regions (2022-2027) Table 11. CNS Specific Antisense Oligonucleotides Market Trends Table 12. CNS Specific Antisense Oligonucleotides Market Drivers Table 13. CNS Specific Antisense Oligonucleotides Market Challenges Table 14. CNS Specific Antisense Oligonucleotides Market Restraints Table 15. Global CNS Specific Antisense Oligonucleotides Revenue by Players (2016-2021) & (US$ Million) Table 16. Global CNS Specific Antisense Oligonucleotides Market Share by Players (2016-2021) Table 17. Global Top CNS Specific Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CNS Specific Antisense Oligonucleotides as of 2020) Table 18. Ranking of Global Top CNS Specific Antisense Oligonucleotides Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by CNS Specific Antisense Oligonucleotides Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players CNS Specific Antisense Oligonucleotides Product Solution and Service Table 22. Date of Enter into CNS Specific Antisense Oligonucleotides Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 25. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Type (2016-2021) Table 26. Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global CNS Specific Antisense Oligonucleotides Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Application (2016-2021) Table 30. Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 33. North America CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 34. North America CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 35. North America CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 36. North America CNS Specific Antisense Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) Table 37. North America CNS Specific Antisense Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 39. Europe CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 41. Europe CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe CNS Specific Antisense Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe CNS Specific Antisense Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America CNS Specific Antisense Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America CNS Specific Antisense Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) Table 62. Akcea Therapeutics, Inc. Company Details Table 63. Akcea Therapeutics, Inc. Business Overview Table 64. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Product Table 65. Akcea Therapeutics, Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) & (US$ Million) Table 66. Akcea Therapeutics, Inc. Recent Development Table 67. Ionis Pharmaceuticals Inc. Company Details Table 68. Ionis Pharmaceuticals Inc. Business Overview Table 69. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Product Table 70. Ionis Pharmaceuticals Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) & (US$ Million) Table 71. Ionis Pharmaceuticals Inc. Recent Development Table 72. Biogen Inc. Company Details Table 73. Biogen Inc. Business Overview Table 74. Biogen Inc. CNS Specific Antisense Oligonucleotides Product Table 75. Biogen Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) & (US$ Million) Table 76. Biogen Inc. Recent Development Table 77. Sarepta Therapeutics Company Details Table 78. Sarepta Therapeutics Business Overview Table 79. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Product Table 80. Sarepta Therapeutics Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) & (US$ Million) Table 81. Sarepta Therapeutics Recent Development Table 82. Wave Life Sciences Ltd. Company Details Table 83. Wave Life Sciences Ltd. Business Overview Table 84. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Product Table 85. Wave Life Sciences Ltd. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) & (US$ Million) Table 86. Wave Life Sciences Ltd. Recent Development Table 87. Dynacure Company Details Table 88. Dynacure Business Overview Table 89. Dynacure CNS Specific Antisense Oligonucleotides Product Table 90. Dynacure Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) & (US$ Million) Table 91. Dynacure Recent Development Table 92. ProQR Therapeutics N.V. Company Details Table 93. ProQR Therapeutics N.V. Business Overview Table 94. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Product Table 95. ProQR Therapeutics N.V. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) & (US$ Million) Table 96. ProQR Therapeutics N.V. Recent Development Table 97. Stroke Therapeutic Inc. Company Details Table 98. Stroke Therapeutic Inc. Business Overview Table 99. Stroke Therapeutic Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2016-2021) & (US$ Million) Table 100. Stroke Therapeutic Inc. Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global CNS Specific Antisense Oligonucleotides Market Share by Type: 2020 VS 2027 Figure 2. Polyneuropathy Treatment Features Figure 3. Spinal Muscular Atrophy (SMA) Treatment Features Figure 4. Huntington’s Disease Treatment Features Figure 5. Global CNS Specific Antisense Oligonucleotides Market Share by Application: 2020 VS 2027 Figure 6. Hospital Pharmacies Case Studies Figure 7. Retail Pharmacies Case Studies Figure 8. Online Pharmacies Case Studies Figure 9. CNS Specific Antisense Oligonucleotides Report Years Considered Figure 10. Global CNS Specific Antisense Oligonucleotides Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global CNS Specific Antisense Oligonucleotides Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global CNS Specific Antisense Oligonucleotides Market Share by Regions: 2020 VS 2027 Figure 13. Global CNS Specific Antisense Oligonucleotides Market Share by Regions (2022-2027) Figure 14. Global CNS Specific Antisense Oligonucleotides Market Share by Players in 2020 Figure 15. Global Top CNS Specific Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CNS Specific Antisense Oligonucleotides as of 2020 Figure 16. The Top 10 and 5 Players Market Share by CNS Specific Antisense Oligonucleotides Revenue in 2020 Figure 17. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Type (2016-2021) Figure 18. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Type (2022-2027) Figure 19. North America CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America CNS Specific Antisense Oligonucleotides Market Share by Type (2016-2027) Figure 21. North America CNS Specific Antisense Oligonucleotides Market Share by Application (2016-2027) Figure 22. North America CNS Specific Antisense Oligonucleotides Market Share by Country (2016-2027) Figure 23. United States CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe CNS Specific Antisense Oligonucleotides Market Share by Type (2016-2027) Figure 27. Europe CNS Specific Antisense Oligonucleotides Market Share by Application (2016-2027) Figure 28. Europe CNS Specific Antisense Oligonucleotides Market Share by Country (2016-2027) Figure 29. Germany CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Share by Type (2016-2027) Figure 37. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Share by Application (2016-2027) Figure 38. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Share by Region (2016-2027) Figure 39. China CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America CNS Specific Antisense Oligonucleotides Market Share by Type (2016-2027) Figure 47. Latin America CNS Specific Antisense Oligonucleotides Market Share by Application (2016-2027) Figure 48. Latin America CNS Specific Antisense Oligonucleotides Market Share by Country (2016-2027) Figure 49. Mexico CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Share by Type (2016-2027) Figure 53. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Share by Application (2016-2027) Figure 54. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Share by Country (2016-2027) Figure 55. Turkey CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Akcea Therapeutics, Inc. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2016-2021) Figure 59. Ionis Pharmaceuticals Inc. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2016-2021) Figure 60. Biogen Inc. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2016-2021) Figure 61. Sarepta Therapeutics Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2016-2021) Figure 62. Wave Life Sciences Ltd. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2016-2021) Figure 63. Dynacure Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2016-2021) Figure 64. ProQR Therapeutics N.V. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2016-2021) Figure 65. Stroke Therapeutic Inc. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Akcea Therapeutics, Inc. Ionis Pharmaceuticals Inc. Biogen Inc. Sarepta Therapeutics Wave Life Sciences Ltd. Dynacure ProQR Therapeutics N.V. Stroke Therapeutic Inc.